Back to Market Feed

Product Information

GLIPIZIDE-METFORMIN 2.5-250 MG is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2803 per EA under NDC 23155011501. Its NADAC has been published 513 times since Nov 28, 2013.

FDA first approved this application on Jun 23, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE-METFORMIN 2.5-250 MG

Glipizide and Metformin HCl
$0.2803per EA

Strength

2.5; 250 mg/1; mg/1

NDC

23155011501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078728

FDA Approved

6/23/2010

TE Code

AB

On Market Since

6/29/2010

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has been published 513 times since Nov 28, 2013, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2803 per EA
All-time high$0.5578 (Mar 16, 2016)
All-time low$0.1748 (Nov 19, 2025)
52-week high$0.3003
52-week low$0.1748
Median price$0.3160
Average price$0.3573
Largest weekly change-42.2% (Oct 17, 2018)
Weeks tracked513
Tracking sinceNov 28, 2013

Price History

1W

-6.4%

1M

-6.4%

3M

+1.5%

6M

+26.3%

1Y

+16.5%

3Y

-2.7%

5Y

-11.3%

All

-26.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Glipizide and Metformin HCl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METFORMIN HCL 500 MG TABLET
Generic
71093013204•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013205•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013206•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
00378718505•Mylan Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
00904716261•Major Pharmaceuticals
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084101•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084105•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084110•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094701•Laurus Labs Limited
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094705•Laurus Labs Limited
$0.0142
per EA

Frequently asked questions

What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-250 MG?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-250 MG, manufactured by Heritage Pharmaceuticals Inc., is $0.2803 per EA (NDC 23155011501), effective Aug 19, 2026.

How has the price of GLIPIZIDE-METFORMIN 2.5-250 MG changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has declined 26.8%. It has been tracked across 513 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-250 MG?

Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has ranged from a low of $0.1748 (Nov 19, 2025) to a high of $0.5578 (Mar 16, 2016), with a median of $0.3160 per EA.

Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-250 MG?

No other NADAC-published product currently shares the active ingredient and strength of GLIPIZIDE-METFORMIN 2.5-250 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLIPIZIDE-METFORMIN 2.5-250 MG?

GLIPIZIDE-METFORMIN 2.5-250 MG (NDC 23155011501) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.